Skip to main content
OpenTrials

Clinical trial condition

EGFR-mutant Lung Cancers

Explore clinical trials studying EGFR-mutant Lung Cancers. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

EGFR-mutant Lung Cancers trial results

Completed

Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers

NCT02803203

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Memoral Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering commack Commack, New York, United States
View Trial Details

Related conditions